Our results also show a worrying trend pointing to an increase in opioid procurement by Israeli HMOs in primary care, now estimated to be at over 90 OME per capita rates.
← all excerpts
Trends and correlated outcomes in population-level prescription opioid and transdermal fentanyl use in Israel.
1
—
—